ASO Author Reflections: Patient-Derived Tumor Xenografts and Ex Vivo Models Mimic the Clinical Response of Locally Aggressive Tumors to Approved Drug Candidates

被引:1
|
作者
Tang, Fan [1 ,2 ]
Tie, Yan [3 ]
Wei, Xiawei [2 ]
Tu, Chongqi [1 ]
机构
[1] Sichuan Univ, Orthoped Res Inst, West China Hosp, Dept Orthopead, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Lab Aging Res & Canc Drug Target, Chengdu, Peoples R China
[3] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp Inst, Sichuan Canc Ctr, Chengdu, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
D O I
10.1245/s10434-021-09840-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:6464 / 6465
页数:2
相关论文
共 13 条
  • [1] ASO Author Reflections: Patient-Derived Tumor Xenografts and Ex Vivo Models Mimic the Clinical Response of Locally Aggressive Tumors to Approved Drug Candidates
    Fan Tang
    Yan Tie
    Xiawei Wei
    Chongqi Tu
    Annals of Surgical Oncology, 2021, 28 : 6464 - 6465
  • [2] Patient-Derived Tumor Xenografts Plus Ex Vivo Models Enable Drug Validation for Tenosynovial Giant Cell Tumors
    Fan Tang
    Yan Tie
    Wei-Qi Hong
    Xin He
    Li Min
    Yong Zhou
    Yi Luo
    Si-Yuan Chen
    Jing-Yun Yang
    Hou-Hui Shi
    Xia-Wei Wei
    Chong-Qi Tu
    Annals of Surgical Oncology, 2021, 28 : 6453 - 6463
  • [3] Patient-Derived Tumor Xenografts Plus Ex Vivo Models Enable Drug Validation for Tenosynovial Giant Cell Tumors
    Tang, Fan
    Tie, Yan
    Hong, Wei-Qi
    He, Xin
    Min, Li
    Zhou, Yong
    Luo, Yi
    Chen, Si-Yuan
    Yang, Jing-Yun
    Shi, Hou-Hui
    Wei, Xia-Wei
    Tu, Chong-Qi
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6453 - 6463
  • [4] In vivo animal models with patient-derived tumor xenografts for better clinical prediction
    Li, Jun
    Kalra, Jessica
    Dinh, Dominic
    Chao, Wan-ru
    Liu, Xiaohe
    Sambucetti, Lidia
    Beviglia, Lucia
    CANCER RESEARCH, 2014, 74 (19)
  • [5] High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
    Gao, Hui
    Korn, Joshua M.
    Ferretti, Stephane
    Monahan, John E.
    Wang, Youzhen
    Singh, Mallika
    Zhang, Chao
    Schnell, Christian
    Yang, Guizhi
    Zhang, Yun
    Balbin, O. Alejandro
    Barbe, Stephanie
    Cai, Hongbo
    Casey, Fergal
    Chatterjee, Susmita
    Chiang, Derek Y.
    Chuai, Shannon
    Cogan, Shawn M.
    Collins, Scott D.
    Dammassa, Ernesta
    Ebel, Nicolas
    Embry, Millicent
    Green, John
    Kauffmann, Audrey
    Kowa, Colleen
    Leary, Rebecca J.
    Lehar, Joseph
    Liang, Ying
    Loo, Alice
    Lorenzana, Edward
    McDonald, E. Robert, III
    McLaughlin, Margaret E.
    Merkin, Jason
    Meyer, Ronald
    Naylor, Tara L.
    Patawaran, Montesa
    Reddy, Anupama
    Roeelli, Claudia
    Ruddy, David A.
    Salangsang, Fernando
    Santacroce, Francesca
    Singh, Angad P.
    Tang, Yan
    Tinetto, Walter
    Tobler, Sonja
    Velazquez, Roberto
    Venkatesan, Kavitha
    Von Arx, Fabian
    Wang, Hui Qin
    Wang, Zongyao
    NATURE MEDICINE, 2015, 21 (11) : 1318 - 1325
  • [6] High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
    Hui Gao
    Joshua M Korn
    Stéphane Ferretti
    John E Monahan
    Youzhen Wang
    Mallika Singh
    Chao Zhang
    Christian Schnell
    Guizhi Yang
    Yun Zhang
    O Alejandro Balbin
    Stéphanie Barbe
    Hongbo Cai
    Fergal Casey
    Susmita Chatterjee
    Derek Y Chiang
    Shannon Chuai
    Shawn M Cogan
    Scott D Collins
    Ernesta Dammassa
    Nicolas Ebel
    Millicent Embry
    John Green
    Audrey Kauffmann
    Colleen Kowal
    Rebecca J Leary
    Joseph Lehar
    Ying Liang
    Alice Loo
    Edward Lorenzana
    E Robert McDonald
    Margaret E McLaughlin
    Jason Merkin
    Ronald Meyer
    Tara L Naylor
    Montesa Patawaran
    Anupama Reddy
    Claudia Röelli
    David A Ruddy
    Fernando Salangsang
    Francesca Santacroce
    Angad P Singh
    Yan Tang
    Walter Tinetto
    Sonja Tobler
    Roberto Velazquez
    Kavitha Venkatesan
    Fabian Von Arx
    Hui Qin Wang
    Zongyao Wang
    Nature Medicine, 2015, 21 : 1318 - 1325
  • [7] Ex vivo models of glioblastoma: a comparison of 3D tissues and patient derived xenografts to clinical response
    Smith, Ashley M.
    Holmes, Lillia
    Dobrolecki, Lacey E.
    Kanos, Charles
    Gardner, Stephen
    Hodge, Philip
    Lynn, Michael
    Edenfield, Jeff
    Lewis, Michael T.
    Crosswell, Howland E.
    DesRochers, Teresa M.
    CANCER RESEARCH, 2019, 79 (13)
  • [8] In vivo drug response evaluation in anaplastic thyroid cancer patient-derived tumor xenografts following high-throughput screening
    Maniakas, Anastasios
    Mohamed, Abdallah S.
    Henderson, Ying C.
    Hei, Hu
    Peng, Shaohua
    Bell, Diana
    Williams, Michelle D.
    Scherer, Steve
    Wheeler, David A.
    Clayman, Gary L.
    Zafereo, Mark
    Wang, Jennifer R.
    Cabanillas, Maria E.
    Stephan, Clifford
    Johnson, Faye M.
    Lai, Stephen Y.
    CANCER RESEARCH, 2020, 80 (16)
  • [9] 'In vitro clinical trials' platform for drug testing in patient-derived ex vivo 3D cultured human tumor tissues
    Beztsinna, N.
    Grillet, F.
    Jariani, A.
    Overkamp, J.
    van der Meer, D.
    Daszkiewicz, L.
    Yan, K.
    Vader, W.
    Price, L.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S59 - S59
  • [10] Enhancing drug discovery and development throughput without sacrificing predictivity: ex vivo 3D drug response profiling (DRP) using patient-derived xenografts (PDX)
    DesRochers, Tessa M.
    Mattingly, Christina
    Shuford, Stephen
    Gevaert, Matthew
    Orr, David
    Bult, Carol
    Airhart, Susie
    Cheng, Mingshan
    Wang, Minan
    Keck, James
    Crosswell, Howland
    CANCER RESEARCH, 2015, 75